Eclutatug (ALE C04) is a humanised antibody targeting claudin-1 (CLDN1), which can be used for the treatment of tumours and organ fibrosis indications, such as head and neck squamous cell carcinoma (HNSCC).
Purity:
95.00%
Target:
Tight Junction Protein
T9901A-389
* VAT and and shipping costs not included. Errors and price changes excepted
